Inhibitor Therapeutics, Inc.
INTI
$0.08
$0.0110.26%
OTC PK
Corporate Info
Website
Phone Number
813 864 2562
Address
3014 West Palmira Avenue
Suite 302
Tampa, FL 33629-7264
Suite 302
Tampa, FL 33629-7264
Country
United States
Year Founded
1992
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
5
Business Description
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies initially for basal cell carcinoma nevus syndrome (BCCNS) cancers by utilizing itraconazole; development of therapies initially for basal cell carcinoma (BCC) cancers; and SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. The company was founded in 1992 and is based in Tampa, Florida.